1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Needle-free Diabetes Care Market Highlights
2.2. Needle-free Diabetes Care Market Projection
2.3. Needle-free Diabetes Care Market Regional Highlights

3. Global Needle-free Diabetes Care Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter’s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Device Type
3.4.2. IGR-Growth Matrix Analysis by End-user
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Needle-free Diabetes Care Market

4. Needle-free Diabetes Care Market Macro Indicator Analysis

5. Global Needle-free Diabetes Care Market by Device Type
5.1. Insulin Patches
5.2. Jet Injectors
5.3. Insulin Pens
5.4. Insulin Pumps
5.5. Insulin Infuser

6. Global Needle-free Diabetes Care Market by End-user
6.1. Diagnostic Centres
6.2. Hospitals and Clinics
6.3. Consumer

7. Global Needle-free Diabetes Care Market by Region 2019-2025
7.1. North America
7.1.1. North America Needle-free Diabetes Care Market by Device Type
7.1.2. North America Needle-free Diabetes Care Market by End-user
7.1.3. North America Needle-free Diabetes Care Market by Country
7.2. Europe
7.2.1. Europe Needle-free Diabetes Care Market by Device Type
7.2.2. Europe Needle-free Diabetes Care Market by End-user
7.2.3. Europe Needle-free Diabetes Care Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Needle-free Diabetes Care Market by Device Type
7.3.2. Asia-Pacific Needle-free Diabetes Care Market by End-user
7.3.3. Asia-Pacific Needle-free Diabetes Care Market by Country
7.4. RoW
7.4.1. RoW Needle-free Diabetes Care Market by Device Type
7.4.2. RoW Needle-free Diabetes Care Market by End-user
7.4.3. RoW Needle-free Diabetes Care Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Needle-free Diabetes Care Market
8.2. Companies Profiles
8.2.1. Antares Pharma, Inc.
8.2.2. European Pharma Group BV
8.2.3. Injex Pharma AG
8.2.4. Pharmajet, Inc.
8.2.5. Bioject Medical Technologies Inc.
8.2.6. 3M
8.2.7. Echo Therapeutics Inc.
8.2.8. MannKind Corporation
8.2.9. Akra Dermojet
8.2.10. Medical International Technology, Inc.
8.2.11. Other companies

9. Appendix
9.1. Primary Research Findings and Questionnaire